464080 — SOS Lab Co Income Statement
0.000.00%
- KR₩191bn
- KR₩171bn
- KR₩5bn
Annual income statement for SOS Lab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 1,215 | 2,336 | 4,103 | 4,936 |
Cost of Revenue | ||||
Gross Profit | 354 | 271 | 1,503 | 1,558 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Total Operating Expenses | 8,206 | 11,944 | 12,430 | 17,767 |
Operating Profit | -6,991 | -9,607 | -8,327 | -12,831 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -18,824 | -20,314 | 6,020 | -11,956 |
Provision for Income Taxes | ||||
Net Income After Taxes | -18,824 | -20,314 | 6,020 | -11,956 |
Net Income Before Extraordinary Items | ||||
Net Income | -18,824 | -20,314 | 6,020 | -11,956 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -18,824 | -20,314 | 6,020 | -11,956 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -1,074 | -1,159 | 343 | -720 |
Dividends per Share |